14 results for “GLENMARK”

Seven stocks that look more attractive after a correction

Markets have fallen. What are you buying? Nifty is down -13% from its peak in Oct 2021 and some stocks have fallen anywhere between -25% to -50%. In this post, we discuss seven companies which are still growing and available at a relatively better valuation after the market correction. Read on.

The IPO rush: Lessons from the past

What's common between the years 2007, 2010, 2017 and 2021? All of them Bull Market years. And far from coincidentally, all of them saw a spate of IPOs as companies rushed to cash in on record-high stock prices. The boom, fuelled by a tsunami of cash unleashed by central banks and the rise of individual investors, eager to buy a piece of their favourite companies. Big bang listings and record oversubscriptions have been the talk of the town lately. Nearly all the 36 IPOs so far in 2021, have witnessed record oversubscription and listing gains. But did you know that 1 in 4 companies that went public in the 2010 boom does not exist anymore? And that more than a decade later, 1 in 2 of those companies is trading below issue price? 2021 is already slated to become the biggest year for primary markets in terms of fundraising. We looked at data on stock performance of companies that went public in past bull markets, to see if there are any lessons for investors subscribing to 2021 IPOs.

China stalls, Rolex rolls and a special offer for you!

The Midcap Carnage and Where There May Be Opportunity

Dr Reddy’s USFDA Inspection of Oncology Formulation Manufacturing Facility at Duvvada – Form 483 Revealed

Dr Reddy’s Laboratories US FDA Inspection of Miryalaguda - Form 483 Revealed

FDA's New Rules Propels Generic and Biosimilar Approvals

EMA agrees to review Mylan and Biocon's Regulatory Submission for proposed biosimilar Pegfilgrastim

Aurobindo, Glenmark and Sun Pharma receive ANDA approval for Rosuvastatin Calcium Tablets

Exclusive: Glenmark Pharmaceuticals form 483 for Pithampur facility

On Slack: The graveyard of corporate raiders, Saudi Life With $30 Oil, Trump and Sanders, Bill Gates Mobile Banking, Fed's Bullard, Barron’s 2016 Roundtable, Luxury tax on ICUs, Adani-Hazira Port, Pendulum Swing and more...

On Slack: L&T Infotech IPO, Airline's fortunes, Coal India, Dalal Street twitterrati, FOMC meet, Stop Orders, The 123 chart pattern and more....

On Slack: India's Coffee King - VGS, RBLs sixer, Suzlon from 'D' to 'BBB-', EM Fire Sales and Patanjali-Future Group marriage and more....

Biggest Losers: Marksans pharma